The development of non-animal research methods is accelerating; organ-on-chip, organoids, and AI models offer promising replacements for many animal tests.
Alternative methods to animal testing are advancing rapidly, driven both by animal welfare concerns and by recognition that animal models often poorly predict human responses to drugs and chemicals. Investment in alternatives research reduces animal use while improving scientific quality. Regulatory acceptance of validated alternatives is a key bottleneck that advocacy and policy can address.